Wavelet indices enhance functional stratification in optic nerve disease, suggesting improved clinical trial endpoints.
Sym2 wavelet indices provide robust and sensitive PERG biomarkers that could serve as quantitative endpoints in clinical trials.
No takes yet. Share an insight, caveat, or question.
Shwetar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: